Pesquisas alternativas:
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
after arm » after warm (Expandir a Pesquisa), after harm (Expandir a Pesquisa), after art (Expandir a Pesquisa)
phase re » phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa), phase rop (Expandir a Pesquisa)
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
after arm » after warm (Expandir a Pesquisa), after harm (Expandir a Pesquisa), after art (Expandir a Pesquisa)
phase re » phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa), phase rop (Expandir a Pesquisa)
1
Por Marty, Francisco M., Man, Choy Y., van der Horst, Charles, Francois, Bruno, Garot, Denis, Máňez, Rafael, Thamlikitkul, Visanu, Lorente, José A., Álvarez-Lerma, Francisco, Brealey, David, Zhao, Henry H., Weller, Steve, Yates, Phillip J., Peppercorn, Amanda F.
Publicado em 2014
“... in viral load of 1.42 log(10) copies/mL after 2 days of treatment. Conclusions. Safety, pharmacokinetic...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Chi, Andrew S, Eisele, Sylvia, Arrillaga-Romany, Isabel, Batchelor, Tracy, Cahill, Daniel, Taylor, Jennie, Cloughesy, Timothy F, Patel, Amie, Delara, Malcolm, Latchman, Sunita, Placantonakis, Dimitris, Pacione, Donato, Fatterpekar, Girish, Shepherd, Timothy, Jain, Rajan, Cordova, Christine, Schafrick, Jessica, Snuderl, Matija, Zagzag, David, Kondziolka, Douglas, Golfinos, John, Silverman, Joshua
Publicado no Neuro Oncol (2017)
“... patients. METHODS: This is a single arm phase II trial with a 6 patient safety lead-in with the primary...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Li, Jie, Zhao, Zhenhua, Du, Guobo, Dai, Tangzhi, Zhen, Xuhai, Cai, Hongwei, Liao, Dongbiao, Xiang, Miao, Wen, Yixue, Geng, Lidan, Yang, Xiyue, Feng, Gang, Zhang, Yu, Bai, Jie, Liu, Lei, Du, Xiaobo
Publicado no Medicine (Baltimore) (2019)
“...INTRODUCTION: Re-irradiation after radiotherapy is a common treatment for locally recurrent...”Publicado no Medicine (Baltimore) (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Song, Yong, Wu, Yi-Long, Cao, Le-Jie, Chen, Jian-Hua, Ma, Zhi-Yong, Cui, Jiu-Wei, Wang, Jie, Liu, Hong-Bing, Ding, Jing-Yan, Hu, Min
Publicado no Am J Clin Oncol (2019)
“... and safety of gefitinib as a third-line re-challenge treatment for advanced NSCLC patients with EGFR mutation...”Publicado no Am J Clin Oncol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Study protocol for an open-label, single-arm, multicentre phase II trial to evaluate the efficacy...
Por Iihara, Hirotoshi, Shimokawa, Mototsugu, Abe, Masakazu, Hayasaki, Yoh, Fujita, Yukiyoshi, Nagasawa, Yuki, Sakurai, Michiru, Matsuoka, Rie, Suzuki, Akio, Morishige, Kenichiro
Publicado no BMJ Open (2019)
“... patients. METHODS AND ANALYSIS: This trial is an open-label, single-arm, multicentre phase II trial...”Publicado no BMJ Open (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Hypolite Muhindo Mavoko, DrPhD, Carolyn Nabasumba, MD, Raquel Inocêncio da Luz, PhD, Halidou Tinto, PhD, Umberto D'Alessandro, ProfPhD, Andrew Kambugu, MD, Vito Baraka, MSc, Anna Rosanas-Urgell, PhD, Pascal Lutumba, ProfPhD, Jean-Pierre Van geertruyden, PhD
Publicado em 2017-01-01
“... and safety of re-treating malaria patients with uncomplicated failures with the same ACT used for the primary...”Publicado em 2017-01-01
Obter o texto integral
Artigo
7
Por Langley, Joanne M., Carmona Martinez, Alfonso, Chatterjee, Archana, Halperin, Scott A., McNeil, Shelly, Reisinger, Keith S., Aggarwal, Naresh, Huang, Li-Min, Peng, Ching-Tien, Garcia-Sicilia, José, Salamanca de la Cueva, Ignacio, Cabañas, Fernando, Treviño-Garza, Consuelo, Rodríguez-Weber, Miguel Angel, de la O, Manuel, Chandrasekaran, Vijayalakshmi, Dewé, Walthère, Liu, Aixue, Innis, Bruce L., Jain, Varsha K.
Publicado em 2013
“...) and vaccine strains occurs frequently. Methods. In a randomized controlled trial, immunogenicity and safety...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Matsusaka, Satoshi, Shinozaki, Eiji, Ozaka, Masato, Ogura, Mariko, Yamaguchi, Toshiharu
Publicado no Drug Des Devel Ther (2015)
“..., Phase II study to evaluate the safety and efficacy of reintroducing oxaliplatin. METHODS: Eligible...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Ailani, Jessica, Lipton, Richard B., Hutchinson, Susan, Knievel, Kerry, Lu, Kaifeng, Butler, Matthew, Yu, Sung Yun, Finnegan, Michelle, Severt, Lawrence, Trugman, Joel M.
Publicado no Headache (2020)
“... with migraine with or without aura entered the trial after completing one of 2 phase 3 lead‐in trials and were...”Publicado no Headache (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Baker, Valerie L., Jones, Christopher A., Doody, Kevin, Foulk, Russell, Yee, Bill, Adamson, G. David, Cometti, Barbara, DeVane, Gary, Hubert, Gary, Trevisan, Silvia, Hoehler, Fred, Jones, Clarence, Soules, Michael
Publicado em 2014
“... IS KNOWN ALREADY: Luteal phase support has been clearly demonstrated to improve pregnancy rates in women...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Ueda, Takeshi, Uemura, Hirotsugu, Tomita, Yoshihiko, Tsukamoto, Taiji, Kanayama, Hiroomi, Shinohara, Nobuo, Tarazi, Jamal, Chen, Connie, Kim, Sinil, Ozono, Seiichiro, Naito, Seiji, Akaza, Hideyuki
Publicado em 2013
“... patients enrolled in the randomized Phase III trial of axitinib versus sorafenib after failure of one prior...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Oehlke, Oliver, Mix, Michael, Graf, Erika, Schimek-Jasch, Tanja, Nestle, Ursula, Götz, Irina, Schneider-Fuchs, Sabine, Weyerbrock, Astrid, Mader, Irina, Baumert, Brigitta G., Short, Susan C., Meyer, Philipp T., Weber, Wolfgang A., Grosu, Anca-Ligia
Publicado no BMC Cancer (2016)
“...- or PET-derived target volumes, rate of long term survivors (>1 year), localization of necrosis after re...”Publicado no BMC Cancer (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Colombo, Nicoletta, Zaccarelli, Eleonora, Baldoni, Alessandra, Frezzini, Simona, Scambia, Giovanni, Palluzzi, Eleonora, Tognon, Germana, Lissoni, Andrea A., Rubino, Daniela, Ferrero, Annamaria, Farina, Gabriella, Negri, Emanuele, Pesenti Gritti, Angela, Galli, Francesca, Biagioli, Elena, Rulli, Eliana, Poli, Davide, Gerardi, Chiara, Torri, Valter, Fossati, Roldano, D‘Incalci, Maurizio
Publicado no Br J Cancer (2019)
“... microenvironment and this could be synergistic with bevacizumab. The efficacy and safety of trabectedin...”Publicado no Br J Cancer (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Wunderink, Richard G, Wunderink, Richard G, Matsunaga, Yuko, Ari, Mari, Ariyasu, Mari, Echols, Roger, Echols, Roger, Menon, Anju, Den Nagata, Tsutae, Den Nagata, Tsutae
Publicado no Open Forum Infect Dis (2019)
“.... Clinical cure rates for major target pathogens at TOC were similar between CFDC and MEM arms (figure...”Publicado no Open Forum Infect Dis (2019)
Obter o texto integral
Obter o texto integral
Artigo
15
Por Moehler, M., Heo, J., Lee, H.C., Tak, W.Y., Chao, Y., Paik, S.W., Yim, H.J., Byun, K.S., Baron, A., Ungerechts, G., Jonker, D., Ruo, L., Cho, M., Kaubisch, A., Wege, H., Merle, P., Ebert, O., Habersetzer, F., Blanc, J.F., Rosmorduc, Olivier, Lencioni, R., Patt, R., Leen, A.M., Foerster, F., Homerin, M., Stojkowitz, N., Lusky, M., Limacher, J.M., Hennequi, M., Gaspar, N., McFadden, B., De Silva, N., Shen, D., Pelusio, A., Kirn, D.H., Breitbach, C.J., Burke, J.M.
Publicado no Oncoimmunology (2019)
“...) and safety. A high drop-out rate in the control arm (63%) confounded assessment of response-based endpoints...”Publicado no Oncoimmunology (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Santos-Ribeiro, Samuel, Mackens, Shari, Tournaye, Herman, Blockeel, Christophe, Stoop, Dominic
Publicado no Hum Reprod Open (2017)
“... rates after ART. Secondary efficacy and safety outcomes include: live-birth delivery after 24 weeks...”Publicado no Hum Reprod Open (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Hurwitz, Mark D., Ghanouni, Pejman, Kanaev, Sergey V., Iozeffi, Dmitri, Gianfelice, David, Fennessy, Fiona Mary, Kuten, Abraham, Meyer, Joshua E., LeBlang, Suzanne D., Roberts, Ann, Choi, Junsung, Larner, James M., Napoli, Alessandro, Turkevich, Vladimir G., Inbar, Yael, Tempany, Clare Mary C., Pfeffer, Raphael M.
Publicado em 2014
“.... This study assessed the safety and efficacy of magnetic resonance-guided focused ultrasound surgery (MRgFUS...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Festin, Mario P.R., Bahamondes, Luis, Nguyen, Thi My Huong, Habib, Ndema, Thamkhantho, Manopchai, Singh, Kuldip, Gosavi, Arundhati, Bartfai, Gyorgy, Bito, Tamas, Bahamondes, M. Valeria, Kapp, Nathalie
Publicado no Hum Reprod (2016)
“..., open-label, single-arm, multicentre Phase III trial study with women who have infrequent coitus (on up...”Publicado no Hum Reprod (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Huang, Jiayi, Chaudhary, Rehka, Cohen, Adam, Fink, Karen, Godlust, Samuel, Boockvar, John, Chinnaiyan, Prakash, Marcus, Stephen, Campian, Jian
Publicado no Neuro Oncol (2018)
“... phase I study demonstrated the safety of combining DSF/Cu with adjuvant TMZ for newly diagnosed GBM...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
20
Por Efremenko, Yuri V, Butov, Dmytro A, Prihoda, Natalia D, Zaitzeva, Svetlana I, Yurchenko, Larisa V, Sokolenko, Nina I, Butova, Tetyana S, Stepanenko, Anna L, Kutsyna, Galyna A, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado em 2013
“... tuberculosis randomized into treatment (n = 22) and placebo (n = 21) arms to investigate the safety...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo